Psychedelic IPOs build momentum as Atai Life Sciences goes public
PITCHBOOK
Making its Wall Street debut, Peter Thiel-backed Atai Life Sciences has become the third biotech...
TORONTO, June 25, 2021 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF, FRANKFURT: 31R), a specialty life sciences company focused on the research and development of...
Therapy Treatment Performed by Ehave’s (EHVVF) Chief Medical Office Dr. Jeffrey Kamlet Received Rave Reviews and Offers the Potential to Save Lives.
MIAMI BEACH, Fla. (CBS12) — Last month,...
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has entered into an exclusive...
Incannex provides investors the best of breed for medicinal cannabis and psychedelic therapy development – and they’re looking at an excursion to the USA
For Incannex Healthcare (ASX:IHL) CEO...
